Immatics at the Allogeneic Cell Therapies Summit 2019 (May 7-9) in Boston, MA (USA)

| News, USA

Meet Immatics at the Allogeneic Cell Therapies Summit 2019 (May 7-9) in Boston, MA and learn about the success factors of Immatics’ immunotherapies:

 

May 8th, 3pm - 3.30pm

Talk: "Novel Allogeneic Cell Therapies for Treatment of Solid Cancers

Speaker: Harpreet Singh (CEO Immatics US)

 

May 9th, 10.30am - 11am

Talk: "ACTallo®: Off-the-Shelf γδ T Cell Therapy Engineered Against Novel Tumor Targets

Speaker: Yannick Bulliard (Director Translational Development)

 

We’re looking forward to interesting and exciting discussions.

Further information on Allogeneic Cell Therapies Summit 2019 here.

Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back

We use cookies to ensure that we give you the best experience on our website.